-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $24

Benzinga·05/14/2026 13:06:35
Listen to the news
Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:ANRO) with a Neutral and raises the price target from $21 to $24.